Andrii Monastyrskyi

10PUBLICATIONS
70CO-AUTHORS
Proteins and peptidesMolecular targetsPharmacogenomicsCheminformatics and quantitative structure-activity relationshipsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 23, 2026
Late-stage functionalization with strain-release warheads enables tunable covalent inhibition.

|Jun 04, 2026
Targeting GSTZ1 Sensitizes KRASG12C-Mutant Lung Cancer Cells by Overcoming Glutathione and Glycolysis Pathway Rewiring.

|Apr 23, 2026
Drug Discovery in Poland and Ukraine.

|Jan 14, 2026
Structure-Activity and Structure-Degradation Relationship Studies of 2-Amino-6-(benzimidazol-2-ylmethyl)-N9-heteroarylpurines as Potent and Selective CDK12/13 Inhibitors and Cyclin K Degraders.

Thiyagamurthy Pandurangan, Solomon Tadesse Zeleke, Anna Iermolaieva

|Oct 30, 2025
Targeting CDK12/13 Drives Mitotic Arrest to Overcome Resistance to KRASG12C Inhibitors.

Yaakov E Stern, Pompom Ghosh, John Peroza

|Nov 21, 2024
Highlights from the Lowlands: Early Career Researchers Shine at Medicinal Chemistry Frontiers 2024.

Sean M McKenna, Chiara Borsari, Sean Chin Chan

Pageof 2

Frequent Collaborators

4 joint publications

Luxin Sun

4 joint publications

Ernst Schönbrunn

3 joint publications

Solomon Tadesse Zeleke

3 joint publications

Derek Duckett